新型冠状病毒抗原检测试剂性能评价相关研究进展

Performance of antigen test for SARS-CoV-2 and related research progress

新型冠状病毒核酸检测阳性是确诊新型冠状病毒肺炎(COVID-19)的金标准。但该项检测需要复杂的仪器,对技术人员专业素质要求高,且耗时较长,因此在应急大规模检测中具有一定的局限性。为满足疫情常态化防控和突发情况应急处理的需求,相关部门发布了新型冠状病毒抗原检测的指导意见,对在特定人群中开展新型冠状病毒抗原检测做出指导,为及时阻断病毒传播提供了新的思路。文章就新型冠状病毒抗原检测试剂性能相关研究进行综述。

Nucleic acid amplification test is the gold standard for the diagnosis of corona virus disease 2019(COVID-19).However,it is inherently difficult to scale up with the reason that it is equipment dependent,technician dependent and time consuming.Recently,relevant departments issued the guidance on severe acute respiratory syndrome virus 2(SARS-CoV-2)antigen test providing guidance for carrying out SARS-CoV-2 antigen test in specific populations,representing a valuable resource in effort to halt the current pandemic.This review aims to briefly summarize the performance of SARS-CoV-2 antigen test.